SE447109B - 2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa - Google Patents

2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa

Info

Publication number
SE447109B
SE447109B SE8003244A SE8003244A SE447109B SE 447109 B SE447109 B SE 447109B SE 8003244 A SE8003244 A SE 8003244A SE 8003244 A SE8003244 A SE 8003244A SE 447109 B SE447109 B SE 447109B
Authority
SE
Sweden
Prior art keywords
hydroxy
piperazinyl
ethyl
methyl
phenyl
Prior art date
Application number
SE8003244A
Other languages
English (en)
Swedish (sv)
Other versions
SE8003244L (sv
Inventor
J M Grisar
G P Claxton
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE8003244L publication Critical patent/SE8003244L/xx
Publication of SE447109B publication Critical patent/SE447109B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8003244A 1979-05-04 1980-04-29 2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa SE447109B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,244 US4255575A (en) 1979-05-04 1979-05-04 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives

Publications (2)

Publication Number Publication Date
SE8003244L SE8003244L (sv) 1980-11-05
SE447109B true SE447109B (sv) 1986-10-27

Family

ID=21887503

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8003244A SE447109B (sv) 1979-05-04 1980-04-29 2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa

Country Status (21)

Country Link
US (1) US4255575A (xx)
JP (1) JPS55147262A (xx)
AT (1) AT376426B (xx)
AU (1) AU531738B2 (xx)
BE (1) BE883086A (xx)
CA (1) CA1138457A (xx)
CH (1) CH645368A5 (xx)
DE (1) DE3014813A1 (xx)
DK (1) DK159435C (xx)
ES (1) ES490667A0 (xx)
FR (1) FR2455590A1 (xx)
GB (1) GB2053897B (xx)
IE (1) IE49549B1 (xx)
IL (1) IL59596A (xx)
IT (1) IT1143190B (xx)
NL (1) NL8002071A (xx)
NO (1) NO152698C (xx)
NZ (1) NZ193107A (xx)
PH (1) PH17089A (xx)
SE (1) SE447109B (xx)
ZA (1) ZA801453B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3400168A1 (de) * 1984-01-04 1985-07-11 Bayer Ag, 5090 Leverkusen 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide
US4616017A (en) * 1984-06-04 1986-10-07 Merck & Co., Inc. Aminohydroxypropoxy substituted aryl compounds
DE3505425A1 (de) * 1985-02-16 1986-08-21 Bayer Ag, 5090 Leverkusen 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamide
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
US4956302A (en) * 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
DE3812755A1 (de) * 1988-04-16 1989-10-26 Merck Patent Gmbh Salicylsaeurederivate
KR100484386B1 (ko) * 2000-10-04 2005-04-22 경동제약 주식회사 알킬2-[2,3,5-트리플루오로-4-(4-메틸-1-피페라지닐)]벤조일-3(s)-(1-히드록시프로피-2-닐아미노)아크릴레이트의 제조방법
US20080131954A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
CA1113937A (en) * 1977-04-05 1981-12-08 Frederic P. Hauck Substituted piperidinylpropanols

Also Published As

Publication number Publication date
ES8104995A1 (es) 1981-05-16
NO152698C (no) 1985-11-20
DE3014813A1 (de) 1980-11-13
FR2455590A1 (fr) 1980-11-28
PH17089A (en) 1984-05-29
NO152698B (no) 1985-07-29
GB2053897B (en) 1982-10-20
IL59596A0 (en) 1980-06-30
CH645368A5 (de) 1984-09-28
IT1143190B (it) 1986-10-22
ZA801453B (en) 1980-12-31
JPS55147262A (en) 1980-11-17
US4255575A (en) 1981-03-10
DK159435C (da) 1991-03-25
DK193680A (da) 1980-11-05
NZ193107A (en) 1982-12-21
AU531738B2 (en) 1983-09-01
DK159435B (da) 1990-10-15
IE800481L (en) 1980-11-04
AT376426B (de) 1984-11-26
IE49549B1 (en) 1985-10-30
ATA232580A (de) 1984-04-15
CA1138457A (en) 1982-12-28
IL59596A (en) 1984-01-31
AU5707680A (en) 1980-11-06
GB2053897A (en) 1981-02-11
JPS6321666B2 (xx) 1988-05-09
IT8048267A0 (it) 1980-03-26
FR2455590B1 (xx) 1983-10-14
BE883086A (fr) 1980-09-01
NL8002071A (nl) 1980-11-06
SE8003244L (sv) 1980-11-05
ES490667A0 (es) 1981-05-16
NO801297L (no) 1980-11-05

Similar Documents

Publication Publication Date Title
RU2075478C1 (ru) 2-(4-этил-1-пиперазинил)-4-(4-фторфенил)-5,6,7,8,9,10-гексагидроциклоокта (в) пиридин или его кислотно-аддитивная соль
US4234584A (en) Substituted phenylpiperazine derivatives
FR2510572A1 (fr) Nouvelles thiazolidinediones, leur procede de production et preparation pharmaceutique les contenant
EP0177392A1 (fr) Nouvelles (pyridyl-2)-1 pipérazines, leur procédé de préparation et leur application en thérapeutique
SE447109B (sv) 2-hydroxi-5-(1-hydroxi-2-piperazinyletyl)-bensoesyraderivat och sett att framstella dessa
CA2405163A1 (en) Soluble beta amyloid precursor protein secretion promoters
EP0008645B1 (de) Alkoxyphenylpyrrolidone, Verfahren zu ihrer Herstellung und Arzneimittel auf Basis dieser Verbindungen
FR2685329A1 (fr) Derives de 3(2h)-pyridazinone et procede pour les preparer.
EP0113587B1 (en) Pyridine derivatives, process for their preparation and pharmaceutical compositions containing them
CA2116881A1 (fr) Composes (aryl(alkyl)carbonyl)-heterocycliques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
EP0735029B1 (en) Benzothiazole derivatives
SE464707B (sv) Nya 2-(difenylmetylpiperazinyl)-1-fenyletanol-derivat, foerfarande foer deras framstaellning samt farmaceutiskt preparat
EP0093945B1 (en) 1,4-dihydropyridine derivatives
FR2637596A1 (fr) Methyl-4 ((aryl-4 piperazinyl-1)-2 ethyl)-5 thiazole et ses derives, leur procede de preparation et les medicaments en contenant
US5013734A (en) Novel esters of phenylalkanoic acid
EP0011372A1 (en) 1-Acyloxyphenyl-1,2-diphenylalkene derivatives, processes for their manufacture and a pharmaceutical composition containing these derivatives
JPH0375542B2 (xx)
CH652119A5 (fr) Derives de l'acide guanidinocyclohexanecarboxylique et leur procede de fabrication.
FR2514003A1 (fr) Nouvelles xanthines a activite pharmacologique, leur procede d'obtention, les compositions pharmaceutiques qui les contiennent et leur utilisation en medecine humaine
US3828030A (en) Chalcone derivatives and preparation thereof
US5468761A (en) 4-methyl-5-substituted-1,3-oxazoles having anti-inflammatory activity
EP0034752B1 (en) Phenoxyalkane derivative and processes for preparing same
JPH0327367A (ja) 新規な2―アミノ―5―アリールオキシメチルオキサゾリンとその塩
FR2619112A1 (fr) Derives de (piperidinyl-4)methyl-2 benzo(b)furo(2,3-c) pyridines, leur preparation et leur application en therapeutique
US4042711A (en) Derivatives of biphenyloxy-lower alkanoic acids, salts thereof and their use as antihyperlipidemics

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8003244-4

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8003244-4

Format of ref document f/p: F